TNF and Behcet disease: In contrast, there is no obvious therapy for anti-TNF failures in BD, with rituximab, cyclophosphamide and alemtuzumab being suggested for consideration in UK treatment pathways for refractory disease (http://www.behcets.nhs.uk/download/behcets-drug-pathway/).